AI-generated summary
The authors retrospectively compared 120 patients with papulopustular rosacea who received red and blue light therapy with paroxetine or light therapy alone for 7 weeks. The combined group showed greater reductions in anxiety, depression and skin symptom scores, and lower serum inflammatory markers, with no significant difference in adverse reactions. The study design was retrospective, so causality cannot be established.
- Participants
- 120
- Who or what was studied
- Patients with papulopustular rosacea treated at a single institution between May 2021 and March 2025
- Limits stated in the abstract
- The study was retrospective, involved a single institution, and the abstract does not describe randomization or blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on termedia.pl.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Anxiety, Control group, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.